| ￥3800 | |
| Z05499-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | |
| Protein Construction |
|
|
| Purity | > 95% as determined by BisTris PAGE | |
| Endotoxin Level | Less than 1EU per μg by the LAL method. | |
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 18 kDa | |
| Apparent Molecular Weight | The protein has a predicted MW of 18 kDa same as Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized IL-33, Human, No Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human IL-1RL1, His Tag with the EC50 of 7.4ng/ml determined by ELISA. »
Immobilized IL-33, Human, No Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-IL-33 antibody, hFc Tag with the EC50 of 4.3ng/ml determined by ELISA. »
The purity of IL-33, Human is greater than 95% as determined by SEC-HPLC. »
IL-33, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Interleukin-33 (IL-33) is a cytokine belonging to the IL-1 family, playing a role in inflammatory, infectious and autoimmune diseases and expressed in the cellular nucleus in several tissues. High levels of IL-33 are expressed in epithelial barrier tissues and endothelial barriers. ST2 is a receptor for IL-33, expressed selectively on a subset of Th2 cells, mediating some of their functions. |
| Synonyms | C9orf26 Z; DVS27; IL1F11; NF-HEV; NFEHEV; IL33; DV27; C9ORF26; RP11-575C20.2 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
